Plain-English translation of NCT05768932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This early-stage trial is testing a new medication called to see if it can help people with advanced cancers that have not responded to standard treatments. The study will test the medication alone and also in combination with other approved cancer drugs, to find safe doses and understand how well it works.
Current treatments for advanced cancers don't work for everyone, and some patients stop responding over time. Researchers are testing this new treatment to see if it offers another option for patients whose cancers have become resistant to existing therapies.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as an intravenous infusion (through a vein) on set days, typically every three weeks. Depending on which study group you're in, you may receive the medication alone or combined with other approved cancer drugs. You'll have regular clinic visits for blood tests, imaging scans, and check-ups to monitor how your body is responding and to watch for any side effects. The study will start with lower doses and gradually increase them as safety is confirmed.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States